INTRAVENOUS PROSTAGLANDINS AND OXYTOCIN FOR MID-TRIMESTER ABORTION
- 18 January 1975
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 305 (7899), 173-174
- https://doi.org/10.1016/s0140-6736(75)91482-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- INDUCTION OF ABORTION BY COMBINED INTRA-AMNIOTIC UREA AND PROSTAGLANDIN E2 OR PROSTAGLANDIN E2 ALONEThe Lancet, 1973
- CONTINUOUS EXTRA‐AMNIOTIC PROSTAGLANDIN E2 FOR THERAPEUTIC TERMINATION AND THE EFFECTIVENESS O VARIOUS INFUSION RATES AND DOSAGESBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- Therapeutic Abortion by Intra-amniotic Injection of ProstaglandinsBMJ, 1972
- Induction of Abortion by Extra-amniotic Administration of Prostaglandins E2 and F2BMJ, 1972
- Intra-amniotic administration of prostaglandin F2α for abortionAmerican Journal of Obstetrics and Gynecology, 1972
- TERMINATION OF PREGNANCY BY CONTINUOUS INTRAUTERINE INFUSION OF PROSTAGLANDINSThe Lancet, 1972
- Prostaglandin-oxytocin Enhancement and Potentiation and their Clinical ApplicationsBMJ, 1972
- THE USE OF PROSTAGLANDIN E2 FOR THERAPEUTIC ABORTIONBJOG: An International Journal of Obstetrics and Gynaecology, 1972
- Induction of abortion by intra-amniotic administration of prostaglandin F2αContraception, 1971
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970